140 related articles for article (PubMed ID: 11527113)
1. Medical interventions in acute myocardial infarction.
Sleight P
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S113-9. PubMed ID: 11527113
[TBL] [Abstract][Full Text] [Related]
2. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.
Yusuf S; Sleight P; Held P; McMahon S
Circulation; 1990 Sep; 82(3 Suppl):II117-34. PubMed ID: 1975522
[TBL] [Abstract][Full Text] [Related]
3. Interventions during and after acute myocardial infarction.
Sleight P
Postgrad Med J; 1983; 59 Suppl 3():80-8. PubMed ID: 6139802
[TBL] [Abstract][Full Text] [Related]
4. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
5. [Integration of therapeutic options and the candidates for treatment: the ABC of the post-infarction period].
Ambrosioni E; Bacchelli S; Borghi C
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():132S-138S. PubMed ID: 9004813
[TBL] [Abstract][Full Text] [Related]
6. [Magnesium sulfate in acute myocardial infarction].
Balli E; Giomi A; Del Citerna F
G Ital Cardiol; 1995 Nov; 25(11):1425-32. PubMed ID: 8682239
[TBL] [Abstract][Full Text] [Related]
7. [Which medical treatment after myocardial infarction?].
Castaigne A; Pham I; Saal JP; Albo C; Verschuren P; Perchet H
Rev Prat; 1992 Nov; 42(17):2169-73. PubMed ID: 1363253
[TBL] [Abstract][Full Text] [Related]
8. Timing, causes, and predictors of death after three years' follow-up in the Danish Multicenter Randomized Study of Fibrinolysis versus Primary Angioplasty in Acute Myocardial Infarction (DANAMI-2) trial.
Busk M; Maeng M; Kristensen SD; Thuesen L; Krusell LR; Mortensen LS; Steinmetz ER; Nielsen TT; Andersen HR;
Am J Cardiol; 2009 Jul; 104(2):210-5. PubMed ID: 19576349
[TBL] [Abstract][Full Text] [Related]
9. Beta-adrenergic blockers in patients with acute myocardial infarction.
Furberg CD; Byington RP
Cardiovasc Clin; 1989; 20(1):235-48. PubMed ID: 2565768
[TBL] [Abstract][Full Text] [Related]
10. Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.
Frilling B; Schiele R; Gitt AK; Zahn R; Schneider S; Glunz HG; Gieseler U; Jagodzinski E; Senges J;
Am Heart J; 2004 Aug; 148(2):306-11. PubMed ID: 15309001
[TBL] [Abstract][Full Text] [Related]
11. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
12. [Secondary prevention after myocardial infarction].
Czuriga I
Orv Hetil; 2002 Sep; 143(37):2117-28. PubMed ID: 12434627
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia.
Keough-Ryan TM; Kiberd BA; Dipchand CS; Cox JL; Rose CL; Thompson KJ; Clase CM
Am J Kidney Dis; 2005 Nov; 46(5):845-55. PubMed ID: 16253724
[TBL] [Abstract][Full Text] [Related]
14. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
15. [Thrombolytic therapy of acute myocardial infarct: which drugs? Which patients?].
Pachinger O; Punzengruber C
Wien Med Wochenschr; 1988 Aug; 138(15-16):373-9. PubMed ID: 3051693
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
17. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
Raos V; Bergovec M
Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
[TBL] [Abstract][Full Text] [Related]
18. Medical management after myocardial infarction: an evidence-based perspective.
Sharpe N
Br J Clin Pract Suppl; 1996 Jul; 84():25-30. PubMed ID: 8994999
[TBL] [Abstract][Full Text] [Related]
19. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
[TBL] [Abstract][Full Text] [Related]
20. Repeat thrombolysis for acute myocardial infarction.
Banerjee P; Clark AL; Norell MS
Int J Cardiol; 2005 Jul; 102(3):515-9. PubMed ID: 16004899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
